Crossmark

Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT)

Published Online: 2024-05-19

Published Print: 2024-08

Authors

Yousefi, Yasamin

Nejati, Reza

Eslahi, Atiye

Alizadeh, Farzaneh

Farrokhi, Shima

Asoodeh, Ahmad

Mojarrad, Majid
License Information

Text and Data Mining valid from 2024-05-19

Version of Record valid from 2024-05-19
More Information

Article History

Received: 29 March 2024

Accepted: 2 May 2024

First Online: 19 May 2024

Declarations

:

: The authors declare no competing interests.

Document is current